Korean drug firms' patent row on rise

Published: 2012-12-27 06:58:00

Updated: 2012-12-27 06:58:00

Korean drug companies will see the number of patent disputes with overseas counterparts surge next year, with a majority of the cases involving accusations of local drug firms breaching patents, data showed Monday.

The number of patent litigations between local and foreign companies reached 18...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK